Tectonic Therapeutic TECX
NASDAQ TECX
$21.96 -0.01 (-0.05%)
At close: Nov 11, 2026 · 4:00 PM EST

Tectonic Therapeutic (TECX) Preferred Stock Liabilities (2017 - 2025)

Updated

Tectonic Therapeutic (TECX) reported Preferred Stock Liabilities of $0.10 for Q4 2025.

Analysis

Tectonic Therapeutic (TECX) Preferred Stock Liabilities (2017 - 2025) Analysis & Trends

  • By year, Preferred Stock Liabilities came in at $80.63 million in FY2023.
  • The Q4 2025 figure ranks as the highest quarterly Preferred Stock Liabilities since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tectonic Therapeutic 437.98 Mn -514.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.10
Dec 31, 2023 80.63 Mn
Dec 31, 2017 26.50 Mn
API Access

Tectonic Therapeutic Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TECX&period=max&api_key=YOUR_API_KEY